InnaMed

InnaMed is a Philadelphia-based medical technology company focused on decentralizing blood testing through its proprietary TeleLab platform. The TeleLab system is a home-based, microfluidic device that enables patients with chronic conditions, such as heart failure and kidney disease, to perform clinical-grade blood tests and transmit results to their physicians. By monitoring biomarkers like NT-proBNP and creatinine, the platform facilitates proactive management and personalized medicine to prevent hospitalizations. InnaMed's technology combines electrochemical biosensors with a user-friendly interface to bridge the gap between clinic visits and home care. The company aims to improve patient outcomes and reduce healthcare costs by enabling more frequent and convenient monitoring of critical health data.